Related Experiment Video
Updated: May 6, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
2.1K
[Metastatic thoracic lymph node carcinoma from extra-thoracic malignancy or from unknown primary site]
P Bagan1, P Mordant1, C Pricopi1
1Service de chirurgie thoracique et transplantation pulmonaire, hôpital européen Georges-Pompidou, hôpitaux universitaires Paris-Ouest, 20, rue Leblanc, 75015 Paris, France.
Revue De Pneumologie Clinique
|November 12, 2013
Summary
Malignant mediastinal lymph nodes, when confined to the chest without lung disease, can be effectively treated with radical surgery. This approach, including lymphadenectomy, offers good long-term results in selected patients as part of multimodality therapy.
Area of Science:
- Oncology
- Thoracic Surgery
- Diagnostic Pathology
Background:
- Malignant mediastinal lymph nodes can originate from lymphoma, thoracic/extrathoracic malignancies, or unknown primary sites.
- Diagnosis is often limited to confirmation due to node dissemination or unresectability.
- Radical surgery is typically reserved for cases without widespread disease.
Purpose of the Study:
- To evaluate the efficacy of radical surgery in managing mediastinal lymph node malignancy.
- To determine if surgical lymphadenectomy is beneficial in selected patients with confined mediastinal disease.
Main Methods:
- Review of institutional experience and case reports.
- Analysis of patients with mediastinal lymph node malignancy and no pulmonary disease.
- Assessment of outcomes following radical surgical lymphadenectomy.
Main Results:
- Long-term positive outcomes were observed in patients undergoing radical surgery for mediastinal lymph node malignancy.
- Surgical lymphadenectomy demonstrated effectiveness in cases without additional thoracic or extrathoracic disease.
Conclusions:
- Radical surgery, including lymphadenectomy, can be a viable and effective treatment option for selected patients with mediastinal metastatic lymph nodes.
- Incorporating surgery into multimodality treatment strategies may improve outcomes for these patients.
Related Concept Videos
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Pulmonary Tuberculosis III
1.8K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.8K

